Search

Author/Creator Hanson, Curtis A.

1. 20+ Years and alive with primary myelofibrosis: Phenotypic signature of very long‐lived patients. Issue 3 (5th December 2018)

Authors:
Penna, Domenico; Lasho, Terra L.; Finke, Christy M.; Vallapureddy, Rangit R.; Hanson, Curtis A.; Ketterling, Rhett P.; Pardanani, Animesh; Gangat, Naseema; Tefferi, Ayalew
Journal:
American journal of hematology
Issue:
Volume 94:Issue 3(2019:Mar.)
Page Start:
286
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3‐ITD mutational status. Issue 12 (17th October 2018)

Authors:
Begna, Kebede H.; Ali, Walid; Gangat, Naseema; Elliott, Michelle A.; Al‐Kali, Aref; Litzow, Mark R.; Hook, C. Christopher; Wolanskyj, Alexandra P.; Hogan, William J.; Patnaik, Mrinal M.; Pardanani, Animesh; Zblewski, Darci L.; Chen, Dong; He, Rong; Viswanatha, David; Hanson, Curtis A.; Ketterling...
Journal:
American journal of hematology
Issue:
Volume 93:Issue 12(2018:Dec.)
Page Start:
E401
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG‐ACRIN cancer research group (E1908). Issue 3 (9th February 2016)

Authors:
Zent, Clive S.; Victoria Wang, Xin; Ketterling, Rhett P.; Hanson, Curtis A.; Libby, Edward N.; Barrientos, Jacqueline C.; Call, Timothy G.; Chang, Julie E.; Liu, Jane J.; Calvo, Alejandro R.; Lazarus, Hillard M.; Rowe, Jacob M.; Luger, Selina M.; Litzow, Mark R.; Tallman, Martin S.
Journal:
American journal of hematology
Issue:
Volume 91:Issue 3(2016:Mar.)
Page Start:
308
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Acute myeloid leukemia after age 70 years: A retrospective comparison of survival following treatment with intensive versus HMA ± venetoclax chemotherapy. Issue 4 (11th March 2021)

Authors:
Begna, Kebede H.; Gangat, Naseema; Al‐Kali, Aref; Litzow, Mark R.; Hogan, William J.; Patnaik, Mrinal M.; Pardanani, Animesh; Hook, C. Christopher; Wolanskyj, Alexandra P.; Elliott, Michelle A.; Hanson, Curtis A.; Ketterling, Rhett P.; Tefferi, Ayalew
Journal:
American journal of hematology
Issue:
Volume 96:Issue 4(2021)
Page Start:
E108
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. ASXL1 and CBL mutations are independently predictive of inferior survival in advanced systemic mastocytosis. (2nd December 2015)

Authors:
Pardanani, Animesh D.; Lasho, Terra L.; Finke, Christy; Zblewski, Darci L.; Abdelrahman, Ramy A.; Wassie, Emnet A.; Gangat, Naseema; Hanson, Curtis A.; Ketterling, Rhett P.; Tefferi, Ayalew
Journal:
British journal of haematology
Issue:
Volume 175:Number 3(2016)
Page Start:
534
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre. (16th August 2018)

Authors:
Hampel, Paul J.; Larson, Melissa C.; Kabat, Brian; Call, Timothy G.; Ding, Wei; Kenderian, Saad S.; Bowen, Deborah; Boysen, Justin; Schwager, Susan M.; Leis, Jose F.; Chanan‐Khan, Asher A.; Muchtar, Eli; Hanson, Curtis A.; Slager, Susan L.; Kay, Neil E.; Chaffee, Kari G.; Shanafelt, Tait D.; Pari...
Journal:
British journal of haematology
Issue:
Volume 183:Number 3(2018)
Page Start:
421
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗